BioSpace News Archive

Press Releases

Silexion Therapeutics Announces Completion of Innovative Expanded Development Plan for SIL204 which will be unveiled at the 2025 NeauxCancer Conference

March 24, 2025

·

4 min read

Press Releases

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results

March 24, 2025

·

14 min read

Vector illustration of pig in graphic style. Drawing by hand.

Drug Development

Gene Editing, Next-Gen Antibodies Key to Unlocking Animal-to-Human Transplants

It’s early days for xenotransplantation, but eGenesis, Eledon, United Therapeutics and more are working to develop solutions to make this approach a viable option and help ease the organ shortage crisis.

March 24, 2025

·

8 min read

·

Kate Goodwin

Press Releases

Opus Genetics Announces Pricing of Public Offering and Concurrent Private Placement with Proceeds of Over $20 Million

March 24, 2025

·

9 min read

Press Releases

PharmAla Completes Shipment of LaNeo™ MDMA to the University of Washington

March 24, 2025

·

3 min read

Press Releases

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program

March 24, 2025

·

8 min read

Empty Wheelchair under Cloud in Desert on a blue sky background. 3d Rendering

Spinal muscular atrophy

6 Therapies on the Horizon for Spinal Muscular Atrophy

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several companies—including Novartis, Scholar Rock and Biogen—progressing novel candidates through clinical trials.

March 24, 2025

·

5 min read

·

Natalia Mesa

Press Releases

Kedrion Expands Ryplazim Distribution Network for PLGD-1 Patients

March 24, 2025

·

4 min read

Press Releases

Sense Neuro Diagnostics appoints Gary Kurdziel as Chief Executive Officer